Delivery Order SPE2DB22D3301-SPE2DB24FY2GF
- Not listed
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. This $6,243.29 contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,111.54 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml pharmaceutical product. The contract, which is a child delivery order under a larger indefinite delivery vehicle, was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025. The award utilized firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will take place at...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The $8,280.78 delivery order has a completion date of January 24, 2024 and was awarded on January 23, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to supply pharmaceuticals, medical...
- The Defense Logistics Agency (DLA) awarded a $22,791.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 ml pharmaceutical product, with a completion date of January 13, 2026. This non-set-aside award represents a task order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The contract will be performed at AmerisourceBergen's corporate office...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,192.00, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,299.52 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562842400 units of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 17, 2023. No set-aside designation was applied to this order, which was awarded against an indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,150.35, is a delivery order for the medication Actemra Actpen 162 mg/0.9 ml. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor. This award is part of a larger $999,999,999.00...
- The Defense Logistics Agency issued a $5,059.92 delivery order to Amerisourcebergen Drug Corp on March 26, 2026, for ACTEMRA ACTPEN 162 MG/0.9 ML pharmaceutical product. The order is placed under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides global pharmaceutical and medical supply support to military healthcare programs. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis...
- This federal contract award, valued at $30,884.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, to support military treatment programs and facilities. This contract award is a delivery order under a larger indefinite delivery contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $15,896.00 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This single-award IDC...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY2GFDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, located in Conshohocken, Pennsylvania. The $13,154.40 contract is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical. The IDC was awarded solely to Amerisourcebergen Drug Corp and does not fall under any overarching contract vehicles. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 3/8/24 |